was successfully added to your cart.

Your SEO optimized title page contents
Michael Mayes BNN Interview

Michael Mayes, CEO of Quantum 9 Inc. Interviewed on BNN Commodities about Canada’s MMPR Program

The interview was conducted by Andrew Bell from BNN Commodities in Toronto, Canada. The interview discussed with Michael Mayes from Quantum 9 and his cannabis consulting opinion on the recent development of Health Canada’s Marihuana for Medical Purposes Regulations (MMPR). Video below:


If you would like the help from the expert marijuana consulting team at Quantum 9 pertaining to your MMPR application submission please fill out the form below.

[contact-form to=’michael@quantum9.net’ subject=’BNN Interview Blog Lead’][contact-field label=’Name’ type=’name’ required=’1’/][contact-field label=’Email’ type=’email’ required=’1’/][contact-field label=’Phone’ type=’text’/][contact-field label=’Comment’ type=’textarea’ required=’1’/][/contact-form]

About Michael Mayes

As Chief Executive Officer for Quantum 9, Inc., Michael has assisted in funding some of the largest commercial cannabis projects in the world. Michael has been a cannabis investor since 2009 in Colorado’s first legal for-profit cannabis market. As the co-founder and CEO of Quantum 9, Inc., Michael has spent years designing technology and collaborating with countless consultants on the forefront of the cannabis industry. Collaborating with the brightest minds and contributing to world-class organizations has been an incredibly enlightening and rewarding experience for him. Also, he has amassed a comprehensive and award-winning team engaged globally for public policy best practices through the prioritization of environmental sustainability and patient care. Michael is a member of the International Cannabinoid Research Society (ICRS), contributor to Marijuana Business Daily, quoted in the Chicago Tribune, Tampa Tribune, Yahoo Finance, Tampa Tribune, Sativa Magazine, CBC and the Daily Herald. His media appearances include several CBS and WGN appearances and international presence on BNN Commodities in Canada. On the public policy front, Michael and his team were instrumental in their work of drafting the Kentucky Medical Marijuana Bill for Senator Perry Clark. Most recently, Michael taught a class for the International Pharmaceutical Academy in Toronto, Canada. He spoke on Cannabis Pharmacology, and the effects cannabis has on the endocannabinoid system.

Leave a Reply